Throat and Other HPV-Related Cancers in Men: Identifying Them Early (TRINITY) (H-49215)
Recruiting men age 50-64, this study aims to develop early detection methods for HPV-related cancers.
HPV-related throat cancer is on the rise, and 80% of cases present themselves after the cancer has already spread. The TRINITY clinical trial is working to establish early screening methods, which could identify cancer before it requires treatment with more long-lasting side effects.
You may qualify if you are a man between the ages of 50 and 64 with no previously documented squamous cell carcinoma of the oropharynx, anus, or penis.
Qualified participants can expect to complete a questionnaire, provide a blood sample, and swish/spit saline.
Individuals identified to be at high risk for HPV-related throat cancer, along with a group of negative controls, will be invited to receive yearly cancer screenings for up to five years.